Chinese aliases: 1-(2-hydroxyethyl) -2-methyl-5-nitroimidazole; 2-methyl-5-nitro-1H-imidazole-1-ethanol; 2-(2-methyl-4-nitro-1-imidazole) ethanol; metronidazole;
Nitrohydroxyethzole; 2-(2-methyl-5-nitro-1-imidazole) ethanol; 2-methyl-5-nitroimidazole-1-ethanol;
English Name: metronidazole
English alias: 2-methyl-5-nitroimidazole-1-ethanol; Eumin; Bexon; Klont; 1H-Imidazole-1-ethanol, 2-methyl-5-nitro-;
Elyzol; 2-(2-Methyl-5-nitro-1-imidazol yl) ethanol; Cont; Klion; 2-Methyl-5-nitroimidazole-1-ethanol; Nalox; Metronidazole; 2-(2-Methyl-5-nitro-1H-imidazol-1-yl) ethanol; Flagil; Nida; ONCLT;
CAS No. 443-48-1
Molecular formula: C6H9N3O3
Molecular weight: 171.15400
Accurate mass: 171.06400
PSA: 83.87000
LogP: 0.61520
Appearance and properties: white to yellowish crystalline powder
Density: 1.45 g/cm 3
Melting point: 159-161 degree C (lit.)
Boiling point: 405.4 C at 760 mmHg
Flash point: 199 C
Refractive index: 1.612
Stability: Stable. Incompatible with strong oxidizing agents.
Storage conditions: 2-8 unitary C
Steam pressure: 2.67E-07mmHg at 25 degrees C
purpose
This product is an anti-amoeba, anti-trichomonas and anti-anaerobic drug. It is a derivative of nitroimidazole. It has the function of anti-anaerobic protozoa and anaerobic bacteria. It is also radiosensitive to hypoxic cancer cells.
Brief Introduction of Compounds
Metronidazole (MNZ), currently circulated under the trade name of Flagyl, is an antibiotic and antiprotozoal medication. It is often used alone or in combination with other antibiotics as a drug for pelvic inflammatory disease, endocarditis and bacterial vaginitis. It is more effective against guinea worm disease, giardiasis, trichomoniasis and amebiasis. This drug is the first priority for patients with first-onset mild to moderate Clostridium difficile colitis. Metronidazole can be treated by oral administration, cream preparation, or intravenous injection. Common side effects include nausea, metallic taste in the mouth, loss of appetite and headache. A few patients may develop Dianxian attacks or allergies. Metronidazole should not be given to pregnant women in the early stages of pregnancy, but there is no such concern in the later stages of pregnancy. In particular, it is not recommended for breastfeeding women. Metronidazole was first widely used in France in 1960. It is also listed in the WHO Essential Medicines Standard List. Especially essential medicines for basic medical care, which can be easily obtained in most countries in the world. The price of this drug is very approachable. The average price of each pill is between 0.01 and 0.1 dollars. In the United States, a ten-day course costs about $26.
Metronidazole High purity imported from the spot
Metronidazole High purity imported from the spot
Metronidazole High purity imported from the spot